A Role for β3-Integrins in Linking Breast Development and Cancer  by Ucar, Ahmet & Streuli, Charles H.
Developmental Cell
PreviewsA Role for b3-Integrins in Linking
Breast Development and CancerAhmet Ucar1 and Charles H. Streuli1,*
1Wellcome Trust Centre for Cell-Matrix Research, Faculty of Life Sciences, University of Manchester, Oxford Road,Manchester M13 9PT, UK
*Correspondence: cstreuli@manchester.ac.uk
http://dx.doi.org/10.1016/j.devcel.2014.07.009
Pregnancy induces a rapid and controlled expansion of mammary stem cells. In this issue of Developmental
Cell, Desgrosellier et al. (2014) show that b3-integrin is required downstream of hormonal signaling and
TGFb2 to regulatemammary stem cell number and alveolar development specifically during early pregnancy.Numerous extraordinary changes in
mammalian physiology mark the early
stages of pregnancy. One of these is the
rapid and exquisitely coordinated prolifer-
ation of epithelial cells in the breast, which
equips the mother for nursing. However,
the question of how mammary epithelial
cells divide so fast and yet become care-
fully crafted into alveoli has not been
solved. Perhaps the answer lies in a
unique period of stem cell expansion
within a specific window of breast devel-
opment, which provides a large number
of cells that can subsequently differen-
tiate into milk factories (Figure 1A). Rapid
proliferation is also a hallmark of cancer
but is fundamentally distinguished from
normal growth by its disorganization. A
new study from Cheresh and colleagues
in this issue of Developmental Cell reveals
that a cell-matrix adhesion receptor, b3-
integrin, may link these events of normal
development and pathology (Desgrosel-
lier et al., 2014).
Integrins are a/b-heterodimeric extra-
cellular matrix adhesion receptors that
regulate cellular responses to their micro-
environment by activating intracellular
signaling (Glukhova and Streuli, 2013).
The most prominent integrins in the
breast are b1-integrin heterodimers;
without them, epithelial cells have severe
defects in proliferation, polarity, milk pro-
duction, and stem cell function. However,
cells express different integrin hetero-
dimers depending on their developmental
stage and microenvironmental context,
and separate epithelial lineages arising
from the same precursors in the breast
can be distinguished on the basis of their
integrin profiles. Luminal cells, which are
adjacent to the luminal space of ducts
and alveoli, express low levels of b1-in-
tegrin and a6-integrin (sometimes knownas CD29 and CD49f, respectively),
while the basal myoepithelial cells and
mammary epithelial stem cells (MaSCs)
express high levels of these integrins
(Figure 1B). A separate integrin subunit,
b3 (CD61), is also expressed in breast
epithelia, and its levels distinguish luminal
progenitors (b3+) from mature, differenti-
ated luminal cells (b3).
The function of b3-integrin in the breast
has not been fully understood. Desgrosel-
lier and colleagues find that this integrin
subunit is crucial for MaSCs at a very
particular time of mammary development,
during the period of alveologenesis
in early pregnancy (Desgrosellier et al.,
2014). Deleting the b3-integrin gene
largely prevents the appearance of al-
veoli, but its absence has no effect on
duct formation or on the differentiation of
luminal precursors into milk-producing
alveolar cells. The increased expression
of b3-integrin in early pregnancy suggests
that this subunit may be under the control
of ovarian hormones, and indeed it
was previously shown that progester-
one might indirectly regulate b3-integrin
expression in MaSCs (Joshi et al., 2010).
The authors of the current study find that
TGFb2, which is also increased during
midpregnancy, is able to induce b3-integ-
rin transcription in MaSCs. The mecha-
nisms controlling integrin expression are
not particularly well understood, so the
observation that the b3-integrin gene
can be transcribed in response to endo-
crine-induced paracrine signals is partic-
ularly intriguing.
The requirement of a specific integrin
subunit for stem cell expansion during
early pregnancy suggests that there may
be previously unidentified changes in the
extracellular matrix (ECM) around newly
forming alveoli that contribute to theirDevelopmental Cell 30development. This would make sense,
given the dramatically different architec-
ture of mammary alveoli in comparison
with ducts and given the specific require-
ment for just alveolar, but not ductal, cells
to proliferate at this time. While it is not
clear whether b3-integrins require ligand
binding for their stem cell activity, fibro-
nectin is present in mammary basement
membranes, so it could be a ligand for
b3-integrins in early alveoli (Woodward
et al., 2001). It would also be valuable to
know whether other b3-integrin ligands
are expressed specifically during early
pregnancy.
In addition to being classically associ-
ated with linking the ECM to the intra-
cellular cytoskeleton, integrins are also
signaling engines. The authors find that
this latter aspect of b3-integrin’s function
is crucial in MaSCs, because cells con-
taining a b3DC knockin allele—which en-
codes a signaling-defective b3 lacking
its C0-terminal three amino acids—display
the same phenotype as those with a full
deletion of the b3-integrin. The integrin-
signaling pathway involves Src family
kinases and stabilization of Slug, a tran-
scription factor previously associated
with MaSCs (Guo et al., 2012).
Thus, Desgrosellier et al. (2014) paint
a new picture of integrins in breast devel-
opment, whereby the pregnancy hor-
mone progesterone indirectly activates
a TGFb2>b3-integrin>SFK>Slug pathway
to increase the number of stem cells in
preparation for lactation. We know that
b1-integrins ensure the self-renewal of
MaSCs by regulating their asymmetric
cell division (Taddei et al., 2008). They
are also required in late pregnancy and
lactation for luminal cell proliferation and
for differentiation into polarized alveoli
that can synthesize and secrete milk, August 11, 2014 ª2014 Elsevier Inc. 251
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Figure 1. Roles for b-Integrins in Breast Development
(A) The requirement of b3-integrins in breast development is restricted to early pregnancy, where there is
an expansion in the numbers of alveoli that subsequently differentiate into polarized milk-producing
epithelial cells in preparation for lactation. (B) Simplified architecture of the breast, showing integrin
expression profile in the stem cells of ducts and alveoli. (C) Left: In resting breast, the stem cell pool is
self-renewed through asymmetric division, most likely requiring b1-integrins. Middle: In early pregnancy,
rapid expansion of stem cells occurs through symmetric divisions coordinated by b3-integrins. Right:
Cancer stem cells rapidly divide to form tumors through symmetric cell division.
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b3-integrinsmay have a unique function in
driving the symmetric division of MaSCs
to rapidly increase their numbers in the
early stages of pregnancy (Figure 1C).
Unfortunately, this developmental con-
trol mechanismmay have disastrous con-252 Developmental Cell 30, August 11, 2014sequences on the rare occasions in which
it becomes dysregulated, particularly in
aggressive tumors in which the cancer
stem cell pool expands through symmet-
ric divisions. Moreover, some aggressive
breast cancers are associated with higher
numbers of tumor-initiating stem cells,ª2014 Elsevier Inc.which probably undergo symmetric divi-
sion more frequently than normal stem
cells (Pece et al., 2010). Thus, it may not
be surprising that b3-integrins are asso-
ciated with aggressive cancer subtypes
(Desgrosellier et al., 2009).
Given that integrin switching to a b3-
dependent process has a central role dur-
ing a stage of breast development that
is nonessential to the mother, targeting
this subunit, and its associated signaling
members, may provide a specific way
to treat cancers without affecting the
host tissue. b3-integrins may also repre-
sent a target for cancer stem cells,
thereby reducing disease progression
and recurrence.
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